Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Ian A Cook, MD
Woman and Man Max 99 years
Ian A Cook, MD
Update Il y a 4 ans
Trigeminal Nerve Stimulation for Depression: Dose Finding
This study will aim to examine the use of external trigeminal nerve stimulation (TNS) as an adjunctive treatment for adults with major depressive disorder (MDD) when added onto antidepress...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Ian A Cook, MD
Update Il y a 4 ans
Brain Mechanisms and Targeting Insomnia in Major Depression
Preliminary studies suggest that the response to antidepressant medication can be accelerated by targeting insomnia with adjunctive use of eszopiclone. It is not yet known what mechanism(s...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Ian A Cook, MD
Update Il y a 4 ans
Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)
This study will aim to evaluate the use of Electroencephalography (EEG) biomarkers in adolescent depression. Two specific hypotheses will be tested: H1: Early decreases in prefrontal cord...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Ian A Cook, MD
Update Il y a 4 ans
Electroencephalography (EEG) Biomarkers of Response in Depression
There are two specific aims of this project: 1. To identify physiologic indicators of venlafaxine treatment response using quantitative EEG (QEEG) cordance, and to determine if cor...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Ian A Cook, MD
Update Il y a 4 ans
Neurophysiologic Predictors of Outcome With rTMS Treatment of Major Depressive Disorder
Transcranial magnetic stimulation (TMS) therapy has proven to lead to symptom improvement in many individuals with major depressive disorder (MDD), yet there is heterogeneity in outcome, w...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Ian A Cook, MD
Update Il y a 4 ans
Biomarkers for Outcomes In Late-life Depression (BOLD)
Major depressive disorder (MDD) is a common psychiatric illness with high cost to society and individual patients. One reason for the high cost is that most patients endure lengthy and ult...
Country
None
organs
None
Specialty
None
Closed trial
More information